Inclusion bodies: A new concept

Microbial Cell Factories

Volumn 9, Issue , 2010, Pages

  García Fruitós, Elena ^a,b  

^a BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; MESSENGER RNA; RECOMBINANT PROTEIN;

BACTERIAL CELL; BIOCATALYSIS; CELL DISRUPTION; CELL INCLUSION; ESCHERICHIA COLI; FREEZE THAWING; GENE DOSAGE; GENE OVEREXPRESSION; GENETIC ENGINEERING; NONHUMAN; NOTE; PROMOTER REGION; PROTEIN AGGREGATION; PROTEIN FOLDING; PURIFICATION; ARTICLE; BIOTECHNOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM;

BIOTECHNOLOGY; ESCHERICHIA COLI; GREEN FLUORESCENT PROTEINS; INCLUSION BODIES; RECOMBINANT PROTEINS;

EID: 77958546977     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-9-80     Document Type: Note

References (40)

1. Marston FA. The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem J 1986, 240:1-12. 1147368, 3548705.
2. Georgiou G, Valax P. Expression of correctly folded proteins in Escherichia coli. Curr Opin Biotechnol 1996, 7:190-197. 10.1016/S0958-1669(96)80012-7, 8791338.
3. Martinez-Alonso M, Garcia-Fruitos E, Ferrer-Miralles N, Rinas U, Villaverde A. Side effects of chaperone gene co-expression in recombinant protein production. Microb Cell Fact 2010, 9:64. 10.1186/1475-2859-9-64, 2944165, 20813055.
4. Martinez-Alonso M, Gonzalez-Montalban N, Garcia-Fruitos E, Villaverde A. Learning about protein solubility from bacterial inclusion bodies. Microb Cell Fact 2009, 8:4. 10.1186/1475-2859-8-4, 2630952, 19133126.
5. Garcia-Fruitos E, Gonzalez-Montalban N, Morell M, Vera A, Ferraz RM, Aris A, et al. Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact 2005, 4:27. 10.1186/1475-2859-4-27, 1224866, 16156893.
6. Vera A, Gonzalez-Montalban N, Aris A, Villaverde A. The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures. Biotechnol Bioeng 2007, 96:1101-1106. 10.1002/bit.21218, 17013944.
7. Garcia-Fruitos E, Aris A, Villaverde A. Localization of functional polypeptides in bacterial inclusion bodies. Appl Environ Microbiol 2007, 73:289-294. 10.1128/AEM.01952-06, 1797118, 17085715.
8. Garcia-Fruitos E, Martinez-Alonso M, Gonzalez-Montalban N, Valli M, Mattanovich D, Villaverde A. Divergent genetic control of protein solubility and conformational quality in Escherichia coli. J Mol Biol 2007, 374:195-205. 10.1016/j.jmb.2007.09.004, 17920630.
9. Garcia-Fruitos E, Rodriguez-Carmona E, Diez-Gil C, Ferraz RM, Vazquez E, Corchero JL, et al. Surface Cell Growth Engineering Assisted by a Novel Bacterial Nanomaterial. Advanced Materials 2009, 21:4249.
10. Garcia-Fruitos E, Seras-Franzoso J, Vazquez E, Villaverde A. Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering. Nanotechnology 2010, 21:205101. 10.1088/0957-4484/21/20/205101, 20413834.
11. Díez-Gil C, Krabbenborg S, Garcia-Fruitos E, Vazquez E, Rodriguez-Carmona E, Ratera I, et al. The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation. Biomaterials 2010, 31:5805-5812. 10.1016/j.biomaterials.2010.04.008, 20452667.
12. Martinez-Alonso M, Garcia-Fruitos E, Villaverde A. Yield, solubility and conformational quality of soluble proteins are not simultaneously favored in recombinant Escherichia coli. Biotechnol Bioeng 2008, 101:1353-1358. 10.1002/bit.21996, 18980180.
13. Martinez-Alonso M, Vera A, Villaverde A. Role of the chaperone DnaK in protein solubility and conformational quality in inclusion body-forming Escherichia coli cells. FEMS Microbiol Lett 2007, 273:187-195. 10.1111/j.1574-6968.2007.00788.x, 17561947.
14. de Groot NS, Ventura S. Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates. J Biotechnol 2006, 125:110-113. 10.1016/j.jbiotec.2006.02.026, 16621081.
15. de Groot NS, Ventura S. Effect of temperature on protein quality in bacterial inclusion bodies. FEBS Lett 2006, 580:6471-6476. 10.1016/j.febslet.2006.10.071, 17101131.
16. Peternel S, Gaberc-Porekar V, Komel R. Bacterial Growth Conditions Affect Quality of GFP Expressed Inside Inclusion Bodies. Acta Chim Slov 2009, 56:860-867.
17. Peternel S, Grdadolnik J, Gaberc-Porekar V, Komel R. Engineering inclusion bodies for non denaturing extraction of functional proteins. Microb Cell Fact 2008, 7:34. 10.1186/1475-2859-7-34, 2630956, 19046444.
18. Jevsevar S, Gaberc-Porekar V, Fonda I, Podobnik B, Grdadolnik J, Menart V. Production of nonclassical inclusion bodies from which correctly folded protein can be extracted. Biotechnol Prog 2005, 21:632-639. 10.1021/bp0497839, 15801811.
19. Tokatlidis K, Dhurjati P, Millet J, Beguin P, Aubert JP. High activity of inclusion bodies formed in Escherichia coli overproducing Clostridium thermocellum endoglucanase D. FEBS Lett 1991, 282:205-208. 10.1016/0014-5793(91)80478-L, 2026260.
20. Worrall DM, Goss NH. The formation of biologically active beta-galactosidase inclusion bodies in Escherichia coli. Aust J Biotechnol 1989, 3:28-32.
21. Nahalka J, Gemeiner P, Bucko M, Wang PG. Bioenergy beads: a tool for regeneration of ATP/NTP in biocatalytic synthesis. Artif Cells Blood Substit Immobil Biotechnol 2006, 34:515-521. 10.1080/10731190600862886, 16893814.
22. Nahalka J, Nidetzky B. Fusion to a pull-down domain: a novel approach of producing Trigonopsis variabilisD-amino acid oxidase as insoluble enzyme aggregates. Biotechnol Bioeng 2007, 97:454-461. 10.1002/bit.21244, 17089401.
23. Nahalka J, Vikartovska A, Hrabarova E. A crosslinked inclusion body process for sialic acid synthesis. J Biotechnol 2008, 134:146-153. 10.1016/j.jbiotec.2008.01.014, 18313163.
24. Nahalka J, Patoprsty V. Enzymatic synthesis of sialylation substrates powered by a novel polyphosphate kinase (PPK3). Org Biomol Chem 2009, 7:1778-1780. 10.1039/b822549b, 19590770.
25. Nahalka J. Physiological aggregation of maltodextrin phosphorylase from Pyrococcus furiosus and its application in a process of batch starch degradation to alpha-D-glucose-1-phosphate. J Ind Microbiol Biotechnol 2008, 35:219-223. 10.1007/s10295-007-0287-4, 18087736.
26. Gonzalez-Montalban N, Natalello A, Garcia-Fruitos E, Villaverde A, Doglia SM. In situ protein folding and activation in bacterial inclusion bodies. Biotechnol Bioeng 2008, 100:797-802. 10.1002/bit.21797, 18351678.
27. Gonzalez-Montalban N, Garcia-Fruitos E, Villaverde A. Recombinant protein solubility - does more mean better?. Nat Biotechnol 2007, 25:718-720. 10.1038/nbt0707-718, 17621288.
28. Nahalka J, Dib I, Nidetzky B. Encapsulation of Trigonopsis variabilis D-amino acid oxidase and fast comparison of the operational stabilities of free and immobilized preparations of the enzyme. Biotechnol Bioeng 2008, 99:251-260. 10.1002/bit.21579, 17680679.
29. Roessl U, Nahalka J, Nidetzky B. Carrier-free immobilized enzymes for biocatalysis. Biotechnol Lett 2010, 32:341-350. 10.1007/s10529-009-0173-4, 19943180.
30. Nahalka J, Mislovicova D, Kavcova H. Targeting lectin activity into inclusion bodies for the characterisation of glycoproteins. Mol Biosyst 2009, 5:819-821. 10.1039/b900526a, 19603115.
31. Sengupta D, Heilshorn SC. Protein-engineered biomaterials: highly tunable tissue engineering scaffolds. Tissue Engineering 2010, 16:285-293. 10.1089/ten.teb.2009.0591, 20141386.
32. Tran N, Webster TJ. Nanotechnology for bone materials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1:336-351. 10.1002/wnan.23, 20049801.
33. Villaverde A. Nanotechnology, bionanotechnology and microbial cell factories. Microb Cell Fact 2010, 9:53. 10.1186/1475-2859-9-53, 2916890, 20602780.
34. Vallejo LF, Rinas U. Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins. Microb Cell Fact 2004, 3:11. 10.1186/1475-2859-3-11, 517725, 15345063.
35. Arii Y, Yamaguchi H, Fukuoka S. Production of a soluble recombinant prion protein fused to blue fluorescent protein without refolding or detergents in Escherichia coli cells. Biosci Biotechnol Biochem 2007, 71:2511-2514. 10.1271/bbb.70303, 17928700.
36. Wanarska M, Hildebrandt P, Kur J. A freeze-thaw method for disintegration of Escherichia coli cells producing T7 lysozyme used in pBAD expression systems. Acta Biochim Pol 2007, 54:671-672.
37. Huang L, Wang J, Zhong Z, Peng L, Chen H, Xu Z, et al. Production of bioactive human beta-defensin-3 in Escherichia coli by soluble fusion expression. Biotechnol Lett 2006, 28:627-632. 10.1007/s10529-006-0024-5, 16642299.
38. Rodriguez-Carmona E, Cano-Garrido O, Seras-Franzoso J, Villaverde A, Garcia-Fruitos E. Isolation of cell-free bacterial inclusion bodies. Microb Cell Fact 2010, 9:71. 10.1186/1475-2859-9-71, 2949796, 20849629.
39. Peternel S, Komel R. Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells. Microb Cell Fact 2010, 9:66. 10.1186/1475-2859-9-66, 2944166, 20831775.
40. Villa R, Lotti M, Gatti-Lafranconi P. Components of the E. coli envelope are affected by and can react to protein over-production in the cytoplasm. Microb Cell Fact 2009, 8:32. 10.1186/1475-2859-8-32, 2701923, 19500339.